Surgery Partners, Inc. beat EPS estimates 50% of the time across 16 reported quarters (8 beats, 8 misses), averaging +3.4% versus consensus. Data sourced from SEC EDGAR.
| Quarter | EPS Estimate | EPS Actual | Surprise | Result | Call |
|---|---|---|---|---|---|
| Q2 FY26 | not reported | $0.07 | not reported | not reported | Q2 FY26 call |
| Q1 FY26 | $-0.17 | $-0.08 | +52.9% | Beat | |
| Q4 FY25 | not reported | $0.10 | not reported | not reported | Q4 FY25 call |
| Q3 FY25 | $0.12 | $0.11 | -8.3% | Miss | |
| Q2 FY25 | not reported | $0.12 | not reported | not reported | |
| Q1 FY25 | $-0.04 | $-0.02 | +50.0% | Beat | |
| Q4 FY24 | $0.38 | $0.39 | +2.6% | Beat | |
| Q3 FY24 | $0.22 | $0.13 | -40.9% | Miss | |
| Q2 FY24 | $0.16 | $0.10 | -37.5% | Miss | |
| Q1 FY24 | $0.04 | $0.06 | +50.0% | Beat | |
| Q4 FY23 | $0.28 | $0.40 | +42.9% | Beat | |
| Q3 FY23 | $0.10 | $0.15 | +50.0% | Beat |
Back to SGRY overview · SGRY holders · SGRY KPIs
Data sourced from U.S. SEC EDGAR filings. Not personalized investment advice.